Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance.
about
Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule ProbesA road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors.Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platformsBivalent enzyme inhibitors discovered using dynamic covalent chemistry.Rhodium-catalyzed NH insertion of pyridyl carbenes derived from pyridotriazoles: a general and efficient approach to 2-picolylamines and imidazo[1,5-a]pyridinesAcyl protein thioesterase inhibitors as probes of dynamic S-palmitoylation.GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitorActivity-based probes for the study of proteases: recent advances and developments.Protein organic chemistry and applications for labeling and engineering in live-cell systems.Structure, function and disease relevance of Omega-class glutathione transferases.Quantification and visualization of glutathione S-transferase omega 1 in cells using inductively coupled plasma mass spectrometry (ICP-MS) and fluorescence microscopy.Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine.Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.Fluorescence polarization assays in high-throughput screening and drug discovery: a reviewGSTO1-1 plays a pro-inflammatory role in models of inflammation, colitis and obesity."Inverse Drug Discovery" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates.Recognition-driven chemical labeling of endogenous proteins in multi-molecular crowding in live cells.Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.Advanced Activity-Based Protein Profiling Application Strategies for Drug Development.A practical fluorogenic substrate for high-throughput screening of glutathione S-transferase inhibitors.
P2860
Q26829985-AC77B7E5-E846-4618-B5CC-DBD06959E27CQ34067085-49DD607A-A2F1-405B-8A6E-175287080FC4Q34228026-F4B4E4D4-168B-475D-B838-30C5EC4D9FA3Q34287232-0415FA99-1E0C-46DA-8DD8-D28B1E7E4C28Q34674736-19110FFA-EB57-4D53-BE00-7DC663ADEDF0Q34789296-D429E76F-579E-490C-BE4D-22E4259B7913Q36044627-7340169A-BFAC-414D-A850-90D1733438B1Q37329941-3B1C612E-3F31-4A0B-A7BF-0FDAF130980FQ37995130-E33EC8C1-A2E7-4A50-A1CB-9E34F8563877Q38083249-FD9D0028-2547-4FD7-9F01-9484CB472B3DQ38780816-C03EA018-24A7-4F62-B9C6-CCF3E8E5ABA0Q38939141-5D433353-5AE2-48EA-BC25-A6A3F0B14623Q39166555-FAC22CFC-0B25-4CB4-85D5-3FDF4F3677FAQ39335230-6B51EB97-F961-4882-8CA7-6B53342E441AQ39493410-27308ABF-F016-424B-80B5-F958BDE2D882Q41467248-1CEBF4C3-3358-4EE7-A582-DE6B908C9F84Q47095354-7D6133AE-EF0A-4FF4-8682-55F61F369360Q47266601-3E6923CC-D50D-4E22-B9F8-54C6FACC4D87Q47449215-03A6C055-95B7-4391-B06C-CBFAC611EE56Q47804072-826746E3-AF67-4E0D-A684-0962AE78B659Q52311693-AE632CFA-916F-4F1C-B5DB-3383B9B76DDFQ52807412-60EAD19B-4E3A-465B-8CEF-5490631EC785
P2860
Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Potent and selective inhibitor ...... impair cancer drug resistance.
@ast
Potent and selective inhibitor ...... impair cancer drug resistance.
@en
type
label
Potent and selective inhibitor ...... impair cancer drug resistance.
@ast
Potent and selective inhibitor ...... impair cancer drug resistance.
@en
prefLabel
Potent and selective inhibitor ...... impair cancer drug resistance.
@ast
Potent and selective inhibitor ...... impair cancer drug resistance.
@en
P2093
P2860
P356
P1476
Potent and selective inhibitor ...... impair cancer drug resistance.
@en
P2093
Anna E Speers
Daniel A Bachovchin
Hugh Rosen
Katsunori Tsuboi
Peter Hodder
Timothy P Spicer
Virneliz Fernandez-Vega
P2860
P304
16605-16616
P356
10.1021/JA2066972
P407
P577
2011-09-27T00:00:00Z